Delivery Order SPE2DB22D2009-SPE2DB25FM0VD
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,835.98 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $18,670.22 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe...
- The Defense Logistics Agency awarded a delivery order valued at $14,005.70 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat conditions such as...
- The Defense Logistics Agency awarded a $54,501.62 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections on August 27, 2025, with ultimate completion by August 28, 2025. This firm fixed-price, competitively awarded contract—without set-aside designation—will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic...
- The Defense Logistics Agency awarded a $27,552.50 delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 6, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily indicated for moderate-to-severe atopic dermatitis, eosinophilic...
- The Defense Logistics Agency awarded a delivery order valued at $132,894.61 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on July 24, 2025. This firm fixed price, non-set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and certain asthma...
- The Defense Logistics Agency awarded a delivery order valued at $49,317.93 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on July 24, 2025, with completion targeted for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis,...
- The Defense Logistics Agency awarded a delivery order valued at $117,847.83 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication commonly prescribed for conditions...
- The Defense Logistics Agency awarded a delivery order valued at $9,380.82 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis,...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.46 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-competitive delivery order utilizes firm fixed price terms and will be performed at the contractor's Conshohocken, Pennsylvania location. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and...